顽固性扁平疣患者接种新型冠状病毒灭活疫苗后皮损自行消退一例  

Flat warts self-cured in a patient after given COVID-19 vaccination: a case report

作　　者：孙右才 孙琦巍 SUN Youcai;SUN Qiwei(Department of Dermatology,Xuchang Central Hospital,Xuchang 461000,China)

机构地区：[1]许昌市中心医院皮肤科,河南许昌461000

出　　处：《中国麻风皮肤病杂志》2022年第4期251-252,共2页China Journal of Leprosy and Skin Diseases

摘　　要：患者,男,26岁。2年前无明显诱因面部、上肢出现多发扁平丘疹,曾多次就诊于我院,诊断为"扁平疣"给予维A酸类药物外用、CO;点阵激光治疗,效果欠佳。2021年5月13日患者行COVID-19-1(Vero Cell)(新型冠状病毒灭活疫苗-北京生物?,批号2021020088)首剂接种,1天后扁平疣皮损变红,自觉瘙痒明显,于2021年5月17日来我院就诊,未予药物治疗,嘱观察,2021年5月23日复诊时疣体枯萎脱落。A 26-year-old male presented with flat warts for 2 years, and was given the treatment of retinoids and CO;lattice laser, with poor therapeutic effect. The Patient was given COVID-19 vaccination(vero cell), Inactivated(Beijing Institute of Biological Products Co., Ltd, Batch Number: 2021020088) on May 13, 2021. The lesions colour turned red, and itching obviously after 1 day of vaccination. No treatment was given when the patient visited the doctor on May 17, 2021. The lesions subsided when the patient visited the doctor on May 23, 2021.

关 键 词：扁平疣 新型冠状病毒疫苗COVID-19 Vaccine(Vero Cell) 

分 类 号：R752.52[医药卫生—皮肤病学与性病学]